Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. by Coburg, AJ et al.
DISAPPEARANCE RATES AND IMMUNOSUPPRESSION 
OF INTERMITTENT INTRA VENOUSL Y ADMINISTERED 
PREDNISOLONE IN RABBITS AND HUMAN BEINGS 
ADOLF J. COBURG, M.D., SAMUEL H. GRAY, M.D., F.A.C.S., FRED H. KATZ, M.D., 
ISRAEL PENN, M.D., CHARLES HALGRIMSON, M.D., and 
THOMAS E. STARZL, M.D., F.A.C.S., Denver, Colorado 
THE IMMUNOSUPPRESSIVE REGIMENS presently 
in clinical use for organ transplantation 
consist of multiple agents, the most widely 
used combinations being azathioprine and 
prednisone (15) or azathioprine, prednisone, 
and heterologous antilymphocyte globulin 
(16). It is generally conceded that the ster-
oids play an indispensable role in the fore-
going therapeutic programs but at the cost 
of major toxicity in the event of daily high 
dose requirements for long periods (16). 
For more than five years in our institution, 
an attempt has been made in selected pa-
tients to reduce the side effects of prednisone 
by giving reduced daily doses supplemented 
by large intermittent injections of intra-
venously administered prednisolone or meth-
ylprednisolone. The indications for such an 
approach have included refractory rejec-
tions as well as infectious complications. 
Under these circum.stances, large intermit-
tent injections of as much as 1 gram of pred-
nisolone have been given every three to ten 
days. 
In view of the empiric nature of this 
practice and because such large doses of 
prednisolone have not been employed be-
fore to our knowledge, this study was under-
taken to determine the duration of the ele-
vated steroid blood levels in human beings 
after an injection, the degree and persistence 
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of the consequent lymphopenia, and the 
immunosuppressive effect of this kind of 
treatment in human beings and in rabbits. 
METHODS 
Animal Studies 
Full thickness skin grafts, 1 centimeter in 
diameter, were exchanged by the method 
of Medawar between 16 New Zealand and 
16 California rabbits which weighed from 
1.7 to 3.9 kilograms. The skin grafts were 
placed on the lateral side of the chest, and 
appropriate autograft controls were per-
formed. Homograft survival was assessed by 
both visual and microscopic examination, 
with rejection being declared on the basis 
of total necrosis of the homograft. 
Eight rabbits, four of each breed, were 
placed in four experimental groups of which 
the first received no immunosuppressive 
treatment. A second group of rabbits was 
given 0.1 milligram per kilogram of methyl-
prednisolone sodium succinate (Solu-Med-
rol®) intramuscularly each day. A third 
group was treated with 0.25 milligram per 
kilogram per day of intramuscularly ad-
ministered methylprednisolone. The fourth 
group of rabbits received a combination of 
the low dose of 0.1 milligram per kilogram 
per day of intramuscularly administered 
methylprednisolone plus a high intravenous 
dose, 10 milligrams per kilogram, every six 
days beginning on the day of grafting. The 
therapy with intramuscularly administered 
methylprednisolone was always begun four 
days prior to the skin transplantation. The 
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TABLE 1. DELAYED HYPERSENSITIVITY SKIN TESTS IN HEALTHY VOLliNTEERS WHO RECEIVED 1 GRAM OF 
PREDNISOLONE TWO HOURS BEFORE THE FIRST ANTIGEN INJECTION 
~umps ___ __ Canrlirla __ ___ Vaccinia __ __ TuberculitL __ 
Antigen __ ._Read ajter __ __ Read ajter __ __ Read aj/er __ __Read ajter __ 
injection 1 day 2 days 3 days 1 day 2 days 3 days 1 day 2 days 3rlays 1 day 2 days 3 days 
1st 0 0 0 0 0 0 +3 +3 
Control +1 +1 +1 0 0 0 
2 1st 0 0 0 0 0 0 +1 +3 +3 
Control +3 +2 +2 +3 
3 1st 0 +1 +1 0 0 0 0 +2 +2 
2nd, 24 hrs. +1 +3 0 ± ± +2 +3 
Control +2 +3 +2 +2 
4 1st 0 +2 +4 0 0 0 +1 +4 0 0 0 
2nd, 48 hrs. +4 +1 +2 +1 
Control +3 +3 +3 +2 +2 +2 +1 
5 lst +1 +3 ± 0 ± ± +1 +4 +4 0 +1 +1 
2nd, 24 hrs. +2 +4 +1 +3 +1 +1 +1 +1 +1 +1 +1 
3rd, 48 hrs. +2 +3 +1 +3 +3 +1 +2 +3 
Control +4 +3 +3 
+1= 1-1.5 em. erythema and 1.5 em. erythema and 4 mm. nodule 5 mm. nodule 
2-3 mm. nodule 5 mm. nodule 
+2 = 2-2.5 em. erythema and 2-3 em. erythema and 6 mm. nodule 6-7 mm. nodule 
3-4 mm. nodule 7 mm. nodule 
+3 == 3-3.5 em. erythema and 3-4 em. erythema and 8 mm. nodule 8-9 mm. nodule 
4-5 mm. nodule 9 mm. nodule 
+4 = > 4 em. erythema and > 4 em. erythema and > 8 mm. nodule with > 10 mm. nodule 
> 5 mm. nodule > 10 mm. nodule necr09is 
powder form of methylprednisolone was 
freshly dissolved in the diluent for each 
day's injections. 
The intramuscular dose of 0.1 milligram 
per kilogram of methylprednisolone cor-
responded to 0.12 milligram of parenterally 
administered prednisolone and to 0.18 mil-
ligram of orally administered prednisone, 
which would be a total dose of 12.5 milli-
grams of orally administered prednisone for 
a man weighing 70 kilograms. The intra-
muscular dose of 0.25 milligram per kilo-
gram of methylprednisolone was equivalent 
to a total of 32 milligrams of prednisone 
administered orally to a man weighing 70 
kilograms. The intravenous dose of 10 milli-
grams of methylprednisolone per kilogram 
in the rabbit was comparable to a total of 1 
gram of prednisolone in a human being. 
Human Studies 
Ten patients were studied for one to three 
days after the intravenous infusion, over 60 
minutes, of 1 gram of prednisolone in 50 
milliliters of 5 per cent glucose in water. 
Five of the ten patients had well functioning 
renal homografts but were imperiled be-
cause of wound infections (Fig. 1) or pneu-
monitis. The other five patients were es-
sentially anephric prior to transplantation 
or had renal homo grafts that had failed. 
Eight of the ten patients were receiving con-
comitant immunosuppressive treatment with 
azathioprine, and seven of these eight were 
also being treated with heterologous anti-
lymphocyte globulin. The other two patients 
who were in the pretransplantation period 
were being given only prednisolone. 
In addition, six healthy persons, including 
some of the authors, volunteered to receive 
1 gram of prednisolone by the same infusion 
technique. Blood samples were taken from 
these volunteers and from the ten patients 
before, at the midpoint, and just after com-
pletion of the infusion. Additional specimens 
were taken one, two, four, eight, 12, 16,24, 
and 48 hours later. In a few instances, 
samples were also drawn after three days. 
When renal failure was not present, the 
subjects were hydrated from two hours be-
fore to two hours after the administration of 
prednisolone, and inulin and hippuran clear-
ances were determined as described else-
where by Popovtzer. Urine samples were 
collected before the prednisolone injection 
and between the times of blood drawing. 
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FIG. 1. An example of the use of intermittent intravenously administered prednisolone in a human 
recipient of a cadaveric renal homograft. One day after transplantation, it was learned that the 
donor had bacteremia, and it was assumed that the operative wound would become infected. Rapid 
steroid withdrawal was combined with intermittent intravenous infusions of 1 gram of prednisolone, 
triangles. The wound was opened widely at three weeks and subsequently healed completely. Eventu-
ally, an adjustment was made in the orally administered prednisone maintenance dosage. Small 
arrows represent intramuscular injections of horse antilymphocyte globulin. 
Plasma 17 -hydroxycorticosteroids were 
measured by Wallace and his colleague's 
modification of the method of Silber and 
Porter. Urinary Porter-Silber chromogens 
were measured by the same technique before 
and after glucuronidase hydrolysis. A Coul-
ter counter was used for white blood counts 
and hematocrit values. The differential 
counts were carried out from 500 leukocytes 
in order to receive more exact absolute 
lymphocyte counts. 
A series of intradermal skin tests was car-
ried out in five of the healthy volunteers to 
determine the effect of a large dose of pred-
nisolone upon delayed hypersensitivity to 
mumps, Candida, vaccinia, and first strength 
purified protein derivative tuberculin. The 
volunteers were known to have been effec-
tively vaccinated against smallpox. They 
also thought themselves to have positive re-
actions to the mumps, Candida, and tuber-
culin antigens. However, to avoid inadver-
tent sensitization, control studies to estab-
lish the existence of these hypersensitivity 
reactions were deferred, and the first intra-
dermal injections of the antigens were made 
two hours after the prednisolone infusion. 
Twenty-four and 48 hours later, second and 
third intradermal doses were repeated. The 
skin reactions were classified from negative 
to 4+ according to the size of the indura-
tion and the area of erythema (Table I). Two 
to four weeks after completion of the pred-
nisolone experiment, the mumps, Candida, 
and tuberculin injections were repeated and 
the results accepted as controls for the pre-
viously performed skin tests. Control tests 
with vaccinia were omitted because de-
layed hypersensitivity was regularly evident 
even under prednisolone treatment. 
RESULTS 
Animal Studies 
The rejection times were approximately 
the same in the New Zealand and California 
rabbits. The mean value of graft survival in 
the eight untreated rabbits of group 1 was 
8.5 ± 1. 8 (standard deviation) days. The rab-
bits of group 2 which were treated with 0.1 
milligram per kilogram per day of ¥1ethyl-
~~--~K ~---~----
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SKIN GRAFTS 
IN RABBITS 
NO THERAPY 
METHYLPREDNISOLONE OJ mg/kg/da Lm. 
METHYLPREDNISOLONE 0.25 mg/kg/day I.m. 
METHYLPREDNISOLONE 0.1 mg/kg/day i.m. 
pius 10 mg/kg Lv. every 6 days 
o 10 
DAYS 
15 
FIG. 2. Rejection times and standard deviations after 
transplantation of full thickness skin grafts to treated 
and untreated rabbits. 
prednisolone had a prolongation of graft 
survival to 12.6± 1.5 (S.D.) days (p<O.OOl). 
With two and one-half times this daily dose 
of methylprednisolone, rejection in group 3 
was further delayed (Fig. 2) to 14.8 ± 1.6 
(S.D.) days (p<O.OOl). The fourth group of 
rabbits given daily low doses of methyl-
prednisolone supplemented with large single 
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injections every six days had the longest 
graft survival, averaging 15.5 ± 2.3 (S.D.) 
days (Fig. 2). The delay of rejection in the 
rabbits of group 4 was statistically significant 
(p<O.OOl) in respect to groups 1 and 2 but 
not to group 3. 
Human Studies 
Subjective reactions.-Of the 16 subjects 
given intravenously administered prednis-
olone, eight complained of pruritus which 
was either generalized or localized to the 
perineal region. Four physicians among the 
six normal volunteers also complained of a 
peculiar taste which was described either as 
metallic or like phenol. One gram of pred-
nisolone sodium phosphate (Hydeltrasol®) 
contains 1.25 grams of nicotinamide, 250 
milligrams of phenol, 25 milligrams of ede-
tate disodium, and 50 milligrams of disodium 
bisulfite. For this reason, the six normal vol-
unteers underwent placebo infusions con-
taining the additives and diluent but no 
16 
HOURS 
24 48 
FIG. 3. Micrograms of Porter-Silber chromogens per 100 milliliters of plasma in 
ten patients and six normal volunteers who were given an intravenous infusion of 
1 gram of prednisolone. Vertical brackets are standard errors of the mean. The 
Porter-Silber chromogen concentrations are expressions of the total plasma steroids. 
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FIG. 4. Comparison of the clearance of prednisolone in six normal, healthy vol-
unteers; five homograft recipients with good kidney function; and five patients 
with essentially no kidney function. The plasma steroid concentration measured as 
Porter-Silber chromogens followed about the same curve in all three groups of sub-
jects. The urinary excretion of steroids in the two groups with renal function is 
expressed in total milligrams of prednisolone. 
prednisolone. The identical symptoms of 
itching and taste aberrations were repro-
duced. 
Prednisolone plasma leuels.-The plasma 
concentrations of Porter-Silber chromogens 
for the six normal volunteers as well as the 
ten transplant patients are represented in 
Figure 3. With the infusion, the plasma lev-
els rose from the rather low pre-existing 
values to peaks that were usually over 1,500 
micrograms per cent. Within a day, or fre-
quentlyeven earlier, the concentrations had 
generally returned to the control status. The 
rapid drop of the plasma levels indicated 
exponential disappearance of the steroid 
with an initial biologic half life of only 60 
to 90 minutes. 
The pattern of changing steroid plasma 
concentrations was somewhat variable be-
tween the six normal subjects, the five trans-
plant recipients with adequate renal func-
tion, and the five patients with essentially 
no renal function (Fig. 4). However, the 
general events of steroid disappearance from 
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FIG. 5. White blood cell and lymphocyte counts in six normal, healthy volunteers who received 
prednisolone infusions. The vertical brackets in the white blood cell eurve represent standard devia-
tions ofthe mean. The lymphocyte counts are shown individually. 
the plasma were the same in these three sub-
groups and did not seem to be critically 
influenced by the presence or absence of 
renal function (Fig. 4). In the six nonnal 
volunteers, it was of interest that the plasma 
steroid levels fell to the subnormal concen-
tration of 5.5 micrograms per cent after 48 
hours, suggesting pituitary-adrenal sup-
pression (Fig. 4). 
Urinary steroid excretion. - Porter-Silber 
chromogens in the urine were quantitated 
before and after glucuronidase hydrolysis. 
Without hydrolysis, the results reflected only 
free steroids, whereas after hydrolysis, the 
results were a measure of total urinary ster-
oids. The latter values which were 50 to 100 
per cent higher than those of free steroids 
are summarized in Figure 4. 
The six normal volunteers had the max-
imum urinary excretion during and just 
after the prednisolone infusion, with a peak 
of 33 milligrams per hour. However, the 
total amount of Porter-Silber chromogens 
recovered in the first day was calculated to 
represent only 131 milligrams of prednis-
olone or 13.1 per cent of the injected dose. 
The five patients in whom renal homografts 
were functioning adequately had a similar 
urinary excretion pattern (Fig. 4) but with 
a total output of only 57 milligrams or 5.7 
per cen t of the original injection. 
Other urinary jindings.-Between 4 and 16 
hours after the prednisolone infusion, the 
urine of the six volunteers which had been 
refrigerated at 4 degrees C. was found to 
contain a precipitate. The urine was acid 
with a pH of 5 to 6, and the precipitates 
were identified as amorphous urates. In three 
of the six volunteers, a positive glucose re-
action developed transiently in the urine two 
to 12 hours after the infusion. 
Hematologic studies. - The white blood 
------------
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FIG. 6. Average lymphocyte counts in six normal volunteers, three patients who were not re-
ceiving heterologous antilymphocyte globulin, and seven patients who were on concomitant therapy 
with the immune globulin. Note that recovery of the lymphocytes seemed to be less prompt in the 
group under treatment with antilymphocyte globulin. 
counts in each of the six healthy volunteers 
are charted in Figure 5. Before the infusion 
was begun, the average count was 6,680 
per cubic millimeter. At four, 16, and 24 
hours, leukocytosis was observed which at 
the last two times was statistically significant 
(p<0.05). At two and three days, the counts 
had returned to normal range. The abso-
lute lymphocyte counts prior to the infusion 
of prednisolone were 2,390 ± 620 (S.D.) per 
cubic millimeter. Two hours after comple-
tion of the steroid injection, highly signifi-
cant depressions of the lymphocyte counts 
occurred (Fig. 5) to a nadir of 630 ± 180 
(S.D.) per cubic millimeter at four hours. 
The lymphopenia persisted for most of the 
first day, and then the lymphocyte counts 
rose to normal or supernormal values. 
In principle, the results in the ten pa-
tients were similar to those in the normal 
volunteers. However, the seven recipients 
who were also receiving azathioprine and 
antilymphocyte globulin had lymphopenia 
which developed more quickly and was 
more prolonged. In these patients, the max-
imum lymphocyte depression to 520±350 
(S.D.) per cubic millimeter occurred at two 
hours after the administration of prednis-
olone and remained significant for most of 
the first day. By 48 hours, there was no re-
bound. The three not being given anti-
lymphocyte globulin had results that were 
intermediate between the healthy volunteers 
and globulin-treated recipients (Fig. 6). 
Hematocrit changes were not noted in 
either the volunteers or the patients. In 
both groups, eosinophiles disappeared for 
two to three days after a prednisolone in-
fusion. The monocyte counts were also de-
pressed, but this was not statistically signifi-
cant at any time. Dramatic morphologic al-
terations were not seen in the cells studied 
on blood smear. 
Delayed hypersensitivity skin tests.-Data on 
the results with skin testing are shown in 
Table I. When either mumps or Candida 
antigen were given two hours after the pred-
nisolone infusion, evidence of a significant 
suppression of response always occurred at 
the time of the one day reading and often 
even at the two and three day readings. If 
these antigens were reinjected 24 or 48 hours 
after the steroid infusion, the delayed hy-
persensitivity reaction expressed itself but 
still subnormally in several patients (Table 
I). The same kinds of observations were 
made in two of the volunteers who were 
tested with tuberculin (Table I). The ster-
oid infusions mitigated the skin reaction to 
vaccinia antigen only slightly (Table I). 
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DISCUSSION 
Adrenocorticoid steroids were the first im-
munosuppressive agents to be systematically 
evaluated. During the several years after the 
first reports by Billingham, and his colleagues 
and by Morgan, there were several con-
firmatory descriptions of the ability of cor-
tisone acetate to significantly delay the 
rejection of first set skin grafts in rodents; 
the same effect was seen in chickens by Can-
non and Longmire. Furthermore, it was 
demonstrated by Krohn, as early as 1954, 
that cortisone acetate could abolish a pre-
existing state of sensitivity induced by full 
thickness skin homografts in rabbits that 
were rejected in about nine days. Thirty-
seven to 60 days after the primary exposure, 
regrafting was carried out with skin from the 
same donor. An accelerated rejection was 
avoided if subcutaneous steroid therapy, 10 
milligrams per day, had been instituted 
several days in advance of the second opera-
tion; in fact, the second transplants often 
survived longer than had been the case with 
the untreated first ones. 
The results with prednisolone and methyl-
prednisolone herein reported were not es-
sen tiall y diff eren t than the pioneering studies 
with cortisone acetate. There was a limited 
but definitive prolongation of survival of 
first skin grafts in rabbits. Moreover, the 
human studies showed that the expression 
of pre-existing hypersensitivity could be 
blunted or, in some cases, prevented alto-
gether. 
The most important new and practical 
questions asked in this investigation were, 
first, if intermittent large doses of steroids 
would significantly potentiate the immuno-
suppression of smaller daily quantities and, 
second, if such a potentiating effect were 
simply due to a chronically elevated blood 
level of the prednisolone or methylpred-
nisolone that lingered on long after the in-
termittent infusions. The answer to the first 
question was yes. In rabbits, the viability 
of full thickness skin grafts was prolonged by 
adding the large intravenous injections every 
six days to the maintenance therapy at 0.1 
milligram per kilogram per day. The results 
were slightly better than those obtained by 
simply increasing the day-to-day doses by 
two and one-half times. 
Information about the second question 
was equally decisive. Improvement in graft 
survival with the intermittent large doses 
was not explainable simply by a persistent 
elevation in the plasma steroids. In both the 
patients and healthy volunteers, 1 gram of 
prednisolone was cleared from the blood 
stream within a day or frequently sooner. 
Similar rapid disappearance rates of cortisol 
have been described in human beings by 
Peterson. \Vith prednisolone, the exact 
mechanism of clearance is not known, al-
though it was clear from the observations 
that renal excretion was not essential for 
the elimination. In patients with well func-
tioning renal homografts and in normal vol-
unteers, the prednisolone recovered from 
the urine was only 5.7 and 13.1 per cent, 
respectively, the exact percentages being a 
rough correlate of the creatinine clearance. 
Moreover, in anephric patients in whom a 
renal pathway of degradation did not exist, 
the prednisolone disappeared from the blood 
stream at a perfectly normal rate. 
The demonstration of such rapid disap-
pearance of the plasma steroids carried the 
implication that the immunosuppressive 
effect of a single high dose outlasted the 
degradation, at least for some hours and 
perhaps for several days. Such an assump-
tion was consistent with the results in the 
animal experiments as well as with the ob-
servation in the human beings who failed to 
respond normally to an antigenic challenge 
given 24 hours after the prednisolone infu-
SIOn. 
It is probable that at least part of the ex-
planation fix the protracted effect from a 
single steroid dose was the lymphopenia 
which occurred promptly and invariably 
and which usually lasted for most of a day. 
The articles by White, Bjorneboe, Gabriel-
son, and by Nelson and their associates could 
be cited in support of this concept since 
they described lymphoid depletion after 
-------------_. 
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steroid therapy. There was no direct evi- pendent on renal function. Lymphopenia 
dence in our experiments that the steroid was produced along with variable changes 
infusions selectively affected the small, long- in the total white blood count. The expres-
lived, antigen-sensitive lymphocytes of thy- sion of delayed hypersensitivity to mumps, 
mic origin as opposed to the large, short- Candida, tuberculin, and vaccinia antigens 
lived lymphocytes which have been said by was either prevented or weakened for at 
Dougherty, Gabrielson, Elves and by Batra least the first day after the steroid injection. 
and their associates to be cortisone-resistant. These experiments support the validity of 
However, the experiments were not specif- a clinical practice that has developed more 
ically designed to obtain this kind of infor- or less empirically in the treatment of homo-
mation. graft recipients, namely the intermittent 
Whatever the reasons for the effectiveness intravenous administration of large quan-
of intermittent high steroid doses, the prac- tities of steroids as a supplement to low 
tice would appear to have merit in immuno- maintenance doses. The additional im-
suppressive regimens. In our clinical ex- munosuppressive effect thereby achieved 
perience, the infusions have been extremely cannot be explained simply by a persistence 
well tolerated, and in the rabbit experi- of plasma steroid levels between the special 
ments, they have seemed to permit mitiga- infusions since the disappearance of the in-
tion of homograft rejection with much travenously administered prednisolone oc-
smaller and safer daily quantities than would curs too rapidly. 
otherwise have been anticipated. With the 
intermittent technique, a number of pa-
tients with major infectious complications 
have been quickly weaned from unaccept-
ably large maintenance doses of prednisone 
but with retention of good homograft func-
tion. 
SUMMARY 
Full thickness skin grafts were exchanged 
between 16 New Zealand and 16 California 
rabbits. Intramuscularly administered meth-
ylprednisolone prolonged the average sur-
vival of the grafts from 8.5 to 12.6 days when 
given in doses ofO.l milligram per kilogram 
per day and to 14.8 days when given in doses 
of 0.25 milligram per kilogram per day. 
When single injections of 10 milligrams per 
kilogram were added intravenously every 
six days to the lesser of the foregoing main-
tenance doses, the graft survived an average 
of 15.5 days. 
Six normal volunteers and ten patients 
with variable renal function were given an 
intravenous infusion of 1 gram of predniso-
lone over 60 minutes The plasma steroid 
levels rose to prodigious heights, but then 
returned to normal within 12 to 24 hours, 
by an elimination process that was not de-
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